Avidity Partners Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $1.84M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $44.3M | Buy |
|
|||||
|
2023
Q2 | $20.4M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4.44M | Hold |
|
|||||
|
2021
Q4 | $3.96M | Hold |
|
|||||
|
2021
Q3 | $3.94M | Hold |
|
|||||
|
2021
Q2 | $4.14M | Hold |
|
|||||
|
2021
Q1 | $4.08M | Hold |
|
|||||
|
2020
Q4 | $4.55M | Buy |
|